Etravirine
CAS 269055-15-4
Overview
Etravirine is a drug used for the treatment of HIV. Etravirine is a non-nucleoside reverse transcriptase inhibitor. Unlike the currently available agents in the class, resistance to other NNRTIs does not seem to confer resistance to etravirine. Etravirine is marketed by Tibotec, a subsidiary of Johnson & Johnson.
Anant Labs manufacture and furnish high quality Etravirine impurities for global markets. Our Etravirine EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.



